596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts

B.Geoerger; N.Hamelin; P.Rodier; P.Opolon; R.Versace; G.Vassal

首页> 外文期刊>European Journal of Cancer Supplements >596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts

【24h】

596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts

机译：596海报在恶性神经胶质瘤异种移植物中，拓扑异构酶I抑制剂gimatecan与替莫唑胺和酪氨酸激酶抑制剂具有协同活性。

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements 》 |2008年第12期| 共2页
作者
B.Geoerger; N.Hamelin; P.Rodier; P.Opolon; R.Versace; G.Vassal;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. 596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts [J] . B.Geoerger, N.Hamelin, P.Rodier, European Journal of Cancer Supplements . 2008 ,第12期

机译：596海报在恶性神经胶质瘤异种移植物中，拓扑异构酶I抑制剂gimatecan与替莫唑胺和酪氨酸激酶抑制剂具有协同活性。
2. 399 POSTER Synergistic antitumor activity of the combination of the multi-targeted tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines [J] . E.Martinelli, T.Troiani, G.Laus, European Journal of Cancer Supplements . 2006 ,第12期

机译：399 POSTER多靶点酪氨酸激酶抑制剂索拉非尼和EGFR抑制剂组合在人结肠癌和肺癌细胞系中的协同抗肿瘤活性
3. 70 POSTER In vitro activity of the multi targeted receptor tyrosine kinase inhibitor sunitinib against multiple myeloma cell lines is not predictive of in vivo xenograft response [J] . M.Batey, J.L.R.Brito, H.Maitland, European Journal of Cancer Supplements . 2008 ,第12期

机译：70 POSTER多靶向受体酪氨酸激酶抑制剂舒尼替尼对多种骨髓瘤细胞系的体外活性不能预测体内异种移植反应
4. Correlation of a Tyrosine Kinase Inhibitor Distribution with Proteome Response in a Glioma Mouse Model by MALDI Imaging Mass Spectrometry [C] . Sara L. Frappier, Richard M. Caprioli ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：MALDI成像质谱法在胶质瘤小鼠模型中对蛋白质组反应的酪氨酸激酶抑制剂分布的相关性
5. The multi-targeted receptor tyrosine kinase inhibitor, linifanib (ABT-869), induces apoptosis and inhibits proliferation of leukemia cells through phosphoinositide-3 kinase (PI3K)/AKT-dependent signaling pathways. [D] . Hernandez, Jenny Elizabeth. 2010

机译：多靶点受体酪氨酸激酶抑制剂利尼法尼（ABT-869）通过磷酸肌醇3激酶（PI3K）/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
6. The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo [O] . Keun-Yong Eom, Bong Jun Cho, Eun Jung Choi, 2016

机译：SRC酪氨酸激酶抑制剂PP2和替莫唑胺化学放疗对恶性胶质瘤细胞体内和体外的影响
7. The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo [O] . Keun-Yong Eom, Bong Jun Cho, Eun Jung Choi, 2016

机译：SRC酪氨酸激酶抑制剂，PP2和替替莫酮对恶性胶质瘤细胞的影响效果在体外，体内

596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts

著录项

相似文献

相关主题

期刊订阅